iShares US Pharmaceuticals ETF
84 hedge funds and large institutions have $157M invested in iShares US Pharmaceuticals ETF in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 36 reducing their positions, and 9 closing their positions.
15,100% more call options, than puts
Call options by funds: $608K | Put options by funds: $4K
3% less funds holding
Funds holding: 87 → 84 (-3)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
16.14% less ownership
Funds ownership: 94.92% → 78.78% (-16%)
20% less capital invested
Capital invested by funds: $197M → $157M (-$39.6M)
50% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 36
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$2.54M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.45M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$796K |
| 4 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
+$761K |
| 5 |
SG Americas Securities
New York
|
+$363K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$15.6M |
| 2 |
SFI
SPC Financial Inc
Rockville,
Maryland
|
-$8.59M |
| 3 |
Goldman Sachs
New York
|
-$7.64M |
| 4 |
EAMA
EFG Asset Management (Americas)
Miami,
Florida
|
-$6.43M |
| 5 |
VF
Virtu Financial
New York
|
-$2.79M |
IHE Hedge Fund Activity: Q3 2016 in Review
84 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q3 2016, worth a combined $157M — down 20% from $197M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of IHE and 8 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 18 added.
The largest buyer was Jane Street, adding an estimated $2.54M. The largest seller was Morgan Stanley, cutting an estimated $15.6M.
- 84 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q3 2016, down from 87 in Q2 2016.
- Funds reported $157M of iShares US Pharmaceuticals ETF stock for Q3 2016, down 20% quarter-over-quarter.
- 8 funds opened new iShares US Pharmaceuticals ETF positions in Q3 2016 and 9 closed out, a net change of -1 holder.
- The largest iShares US Pharmaceuticals ETF buyer in Q3 2016 was Jane Street, an estimated $2.54M added.
- The largest iShares US Pharmaceuticals ETF seller in Q3 2016 was Morgan Stanley, an estimated $15.6M sold.
Based on aggregated 13F filings for Q3 2016.